Connected profileElamipretide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
MTP-131 clinical trials
1 selected ClinicalTrials.gov records carrying the official matched intervention MTP-131 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
1 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 39 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT02693119
PeptideScanner retained ClinicalTrials.gov record NCT02693119 at 2026-07-30T19:56:31.565Z. Its registry update date was 2021-11-30, and PeptideScanner's reviewed identity mapping was elamipretide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- November 30, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Elamipretide · 2021-11-30
ClinicalTrials.gov record NCT02693119
Completed at the retained observation.
Open attributed record →